References
- GreensponAJPatelJDLauE16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008J Am Coll Cardiol2011581001100621867833
- BaddourLMBettmannMABolgerAFNonvalvular cardiovascular device-related infectionsCirculation20031082015203114568887
- BaddourLMEpsteinAEEricksonCCUpdate on cardiovascular implantable electronic device infections and their managementCirculation201012145847720048212
- ByrdCLWilkoffBLLoveCJSellersTDReiserCClinical study of the laser sheath for lead extraction: the total experience in the United StatesPacing Clin Electrophysiol20022580480812049372
- FergusonTBJrFergusonCLCritesKCrimmins-RedaPThe additional hospital costs generated in the management of complications of pacemaker and defibrillator implantationsJ Thorac Cardiovasc Surg19961117427758614134
- SohailMRUslanDZKhanAHManagement and outcome of permanent pacemaker and implantable cardioverter-defibrillator infectionsJ Am Coll Cardiol200749181851185917481444
- National Nosocomial Infections Surveillance (NNIS) System ReportNational nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004Am J Infect Control200432847048515573054
- SohailMRUslanDZKhanAHInfective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infectionMayo Clin Proc2008811465318174000
- RohacekMWeisserMKobzaRBacterial colonization and infection of electrophysiological cardiac devices detected with sonication and swab cultureCirculation2010121151691169720368521
- KolodzinskaAKutarskiAKozlowskaMBiodegradation of the outer silicone insulation of endocardial leadsCirc Arrhythm Electrophysiol2013627928623476031
- HansenLKBergKJohnsonDSandersMCitronMEfficacy of local rifampin/minocycline delivery (AIGIS(RX)®) to eliminate biofilm formation on implanted pacing devices in a rabbit modelInt J Artif Organs201033962763520963727
- AgostinhoAJamesGWazniOCitronMWilkoffBDInhibition of Staphylococcus aureus biofilms by a novel antibacterial envelope for use with implantable cardiac devicesClin Transl Sci20092319319820443892
- BloomHLConstantinLDanDCOoperative Multicenter study Monitoring a CIED ANtimicrobial Device InvestigatorsImplantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelopePacing Clin Electrophysiol201134213314220942819
- KolekJMDresdenWFWellsQSEllisCRUse of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patientsPacing Clin Electrophysiol201336335436123252988
- MittalSShawREMichelKCardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelopeHeart Rhythm201411459560124333543
- GouldPAKrahnADComplications associated with implantable cardioverter-defibrillator replacement in response to device advisoriesJAMA2006295161907191116639049
- KrahnADLeeDSBirnieDOntario ICD Database InvestigatorsPredictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD databaseCirc Arrhythm Electrophysiol20114213614221325209
- The Heart Rhythm Society’sMDT in mile high 4F citadel/centurion study interim analysis: use of an antibacterial envelope is associated with very low 90-day CIED infection rates heart rhythm 201334th annual scientific sessions. presented in: late-breaking clinical trials session III; Saturday, 8:00 am – 9:30 amMay 11, 2013Denver
- HenriksonCACitadel & Centurion studies. Poster presented at European Heart Rhythm Association (EHRA)Cardiostim2014